Biotech jobs in France: science, engineering and data roles
600 open roles at 98 biotech, pharma and life science companies in France: Research science (91), Clinical, regulatory and drug development (84), Process and manufacturing engineering (31), Lab and field technicians (189), Data, AI and bioinformatics (34), Product, operations and leadership (58), Graduates and internships (88). None of them states a citizenship or security-check demand. 6 mention relocation support.
aqemia.com · HQ: Paris, France · AI for Science · Drug Discovery · 51-200 employees · Est. 2019 · Startup · Hiring 8, 4 new
HQ: Paris, France · AI for Science · Drug Discovery · 51-200 employees · Est. 2019 · Startup · Hiring 8, 4 new
Aqemia is a Paris company founded in 2019 that designs drug candidates with quantum-inspired statistical physics and deep learning. Its platform predicts binding affinity without experimental training data, allowing very large virtual screening campaigns. The company runs its own therapeutic programmes and partners with pharmaceutical groups such as Sanofi.
sanofi.com · HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 718, 113 new
HQ: Paris, France · Vaccines · Rare Disease Therapeutics · Immunology & Inflammation Therapeutics · Prescription Drugs · 1001-5000 employees · Est. 1973 · NASDAQ: SNY · Trust A · Hiring 718, 113 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
novonordisk.se · HQ: Bagsværd, Denmark · Biologics & Biosimilars · Cardiometabolic Therapeutics · Prescription Drugs · 5000+ employees · Est. 1923 · Trust A · Hiring 83, 48 new
HQ: Bagsværd, Denmark · Biologics & Biosimilars · Cardiometabolic Therapeutics · Prescription Drugs · 5000+ employees · Est. 1923 · Trust A · Hiring 83, 48 new
Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd near Copenhagen that develops and manufactures treatments for diabetes, obesity, haemophilia, growth disorders and other serious chronic diseases. This record is its Swedish website, run by Novo Nordisk Scandinavia AB in Malmö, while the group, with roots going back to 1923, operates production and research sites in Denmark, the United States, France, Japan, China and Brazil among others. The shared global careers board lists roles in process and analytical science, manufacturing and automation engineering, IT and cyber security, logistics, finance and regulatory writing.
excelya.com · HQ: Paris, France · Clinical Trial Services (CRO) · 501-1000 employees · Est. 2014 · Trust A · Hiring 29, 5 new
HQ: Paris, France · Clinical Trial Services (CRO) · 501-1000 employees · Est. 2014 · Trust A · Hiring 29, 5 new
Excelya is a European contract research organisation that supports pharmaceutical, biotechnology and medical device companies in clinical development. It offers full-service clinical trial management, functional service provision and staff resourcing in clinical operations, regulatory affairs, quality assurance and biometrics, with teams in France, Belgium, Germany, Greece and other countries. The company is headquartered in Paris, France.
Roche is a Swiss healthcare group founded in Basel in 1896 and is unusual in operating two large divisions of comparable importance: prescription medicines and in vitro diagnostics. The pharmaceutical business is built on oncology, neurology, immunology, ophthalmology and haemophilia, with products such as Ocrevus, Hemlibra, Perjeta and Vabysmo, while the diagnostics division supplies laboratory analysers, molecular tests and sequencing systems to hospitals worldwide. The group owns the American biotechnology company Genentech outright and the Japanese firm Chugai in majority, is controlled by a family shareholder pool, and spends among the largest research budgets in the industry.
ceva.com · HQ: Libourne, France · Vaccines · Veterinary Medicine · 5000+ employees · Est. 1999 · NASDAQ: CEVA · Trust A · Hiring 75, 4 new
HQ: Libourne, France · Vaccines · Veterinary Medicine · 5000+ employees · Est. 1999 · NASDAQ: CEVA · Trust A · Hiring 75, 4 new
Ceva Santé Animale is a French animal health company headquartered in Libourne that develops, manufactures and sells veterinary medicines, vaccines and welfare products for livestock, poultry and companion animals. Founded in 1999 through a management buyout of the animal health business of Sanofi, it has grown into one of the largest animal health companies in the world, with research centres, production plants and subsidiaries across Europe, the Americas, Asia and Africa. It hires veterinary service managers, research and development project managers, manufacturing leaders, regulatory and quality staff and sales teams.
Companies whose main business is biotechnology, drug discovery and development, cell and gene therapy, genomics, contract research and manufacturing (CRO, CDMO) or life science tools - and every role whose title names biotech work at any employer. Their sales, finance and office roles are left out: these pages list the science, engineering, data and IT roles.
How fresh is this?
Every role is re-checked on the employer's own careers board at least every 48 hours, and the page is rebuilt every night.
Cerba HealthCare
Sanofi
Pierre Fabre
AbbVie
Ipsen
LFB
Excelya
Veeva Systems
Ceva Santé Animale
Thermo Fisher Scientific
Lesaffre
Sartorius
Evotec
GSK
Merck Group
